Clinical trials: Hyperphosphatemia Patients on Hemodialysis
Hyperphosphatemia
The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
Hyperphosphatemia is a common problem in hemodialysis (HD) patients. Different chelators for control of Hyperphosphatemia are used.
- Trial name
- NCT01854437
- Testing
- Mg Oxide
- Where
- Iran
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Shiraz University of Medical Sciences